Leukotriene receptor antagonists for the treatment of asthma.

  • James P Kemp
  • Published 2000 in IDrugs : the investigational drugs journal


Leukotriene receptor antagonists (LTRAs) are novel medications that provide symptom control in patients with persistent asthma. Current guidelines recommend the use of LTRAs as a treatment option for patients with mild-persistent asthma of at least 12 years of age. As illustrated by the results of controlled, multicenter clinical trials with zafirlukast and… (More)


Cite this paper

@article{Kemp2000LeukotrieneRA, title={Leukotriene receptor antagonists for the treatment of asthma.}, author={James P Kemp}, journal={IDrugs : the investigational drugs journal}, year={2000}, volume={3 4}, pages={430-41} }